• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIN8bio
    Picture of IN8bio logo

    INAB — IN8bio Share News

    $1.050.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapNeutral
    • Market Cap
      $10.35m
    • Enterprise Value
      -$7.48m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • INAB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    INAB Dividends
    • Brief: In8bio Reports Second Quarter 2021 Financial Results And Provides Corporate Update

      10/09/2021 22:24
    • Brief: IN8bio Announces First Patient Cohort Dosed In Phase 1 Clinical Trial Of INB-100

      11/08/2021 13:42
    • Brief: IN8bio Appoints Emily Fairbairn And Luba Greenwood To Board

      04/08/2021 13:32
    • Brief: In8bio Inc Shares Open Flat In Debut On Nasdaq

      30/07/2021 16:41
    • Brief: In8bio Announces Pricing Of Initial Public Offering

      30/07/2021 12:09
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM

      30/07/2021 09:01
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM

      29/07/2021 09:01
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM

      28/07/2021 09:01
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

      12/11/2020 09:01
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.